Androgel
Please select a testosterone article from the list below:
- Business Wire - Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal® as Compared to Topical Testim® Examining Effects on Male Fertility...
- PR Newswire - New Subset Analysis of AndroGel® Data Highlights Efficacy - Regardless of BMI
- Business Wire - Repros Therapeutics Inc. Reports Second Quarter 2007 Financial Results
- Business Wire - Repros' Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
- Chain Drug Review - FDA first-time generics approvals--2006.(Special Report)(Statistical table)
- Business Wire - Zacks Bull and Bear of the Day Highlights: Trident Microsystems, Auxilium Pharmaceuticals, Progressive Corporation and Parker Hannifin
- Business Wire - Research and Markets: Fenofibrate is Solvay Pharmaceuticals Flagship Product and Principal Growth Driver
- Business Wire - Repros' Androxal Shows Noninferiority in Interim Phase 3 Analysis
- Business Wire - Zacks Bull and Bear of the Day Highlights: Acusphere, Auxilium Pharmaceuticals, Wintrust Financial and United Microelectronics
- BIOTECH Patent News - Watson and Unimed settle lawsuit over testosterone gel.
Monday 30th of June 2008
Business Wire - Repros Therapeutics Inc. Initiates a Comparative Phase 2b Study of Oral Androxal® as Compared to Topical Testim® Examining Effects on Male Fertility...
Monday 30th of June 2008, 12:00 amJune 30, 2008 -- Provides Guidance on Proellex Endometriosis Phase 2 Data and Initiation of Androxal Phase 2b Study for the Treatment of Hyperglycemia THE...
Tuesday 17th of June 2008
PR Newswire - New Subset Analysis of AndroGel® Data Highlights Efficacy - Regardless of BMI
Tuesday 17th of June 2008, 12:00 amJune 17, 2008 -- MARIETTA, Ga., June 17 /PRNewswire/ -- Solvay Pharmaceuticals, Inc. announced today that a new analysis of pivotal study data conducted by the Los...
Wednesday 8th of August 2007
Business Wire - Repros Therapeutics Inc. Reports Second Quarter 2007 Financial Results
Wednesday 8th of August 2007, 12:00 amAugust 8, 2007 -- THE WOODLANDS, Texas -- Repros Therapeutics (NasdaqGM: RPRX) today announced financial results for the three-month and six-month periods ended June...
Tuesday 5th of June 2007
Business Wire - Repros' Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
Tuesday 5th of June 2007, 12:00 amJune 5, 2007 -- Non-Inferiority to Market Leading Drug Demonstrated in Six Month Study THE WOODLANDS, Texas -- Repros Therapeutics Inc. (NasdaqGM:RPRX) announced...
Monday 19th of February 2007
Chain Drug Review - FDA first-time generics approvals--2006.(Special Report)(Statistical table)
Monday 19th of February 2007, 12:00 amFebruary 19, 2007 -- FDA First-Time Generics Approvals--2006 GENERIC DRUG NAME MANUFACTURER BRAND NAME JANUARY Isradipine capsules Abrika...
Friday 26th of January 2007
Business Wire - Zacks Bull and Bear of the Day Highlights: Trident Microsystems, Auxilium Pharmaceuticals, Progressive Corporation and Parker Hannifin
Friday 26th of January 2007, 12:00 amJanuary 26, 2007 -- CHICAGO -- Zacks Equity Research highlights Trident Microsystems, Inc. (Nasdaq: TRID) as the Bull of the Day and Auxilium Pharmaceuticals (Nasdaq:...
Friday 12th of January 2007
Business Wire - Research and Markets: Fenofibrate is Solvay Pharmaceuticals Flagship Product and Principal Growth Driver
Friday 12th of January 2007, 12:00 amJanuary 12, 2007 -- DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c48366) has announced the addition of the Espicom Business...
Wednesday 20th of December 2006
Business Wire - Repros' Androxal Shows Noninferiority in Interim Phase 3 Analysis
Wednesday 20th of December 2006, 12:00 amDecember 20, 2006 -- THE WOODLANDS, Texas -- Repros Therapeutics Inc. (NasdaqGM:RPRX)(PCX:RPRX) announced interim results of a U.S. Phase 3 study of Androxal[TM], an oral...
Wednesday 13th of December 2006
Business Wire - Zacks Bull and Bear of the Day Highlights: Acusphere, Auxilium Pharmaceuticals, Wintrust Financial and United Microelectronics
Wednesday 13th of December 2006, 12:00 amDecember 13, 2006 -- CHICAGO -- Zacks Equity Research highlights Acusphere, Inc. (Nasdaq: ACUS) as the Bull of the Day and Auxilium Pharmaceuticals (Nasdaq: AUXL) as the...
Friday 1st of September 2006
BIOTECH Patent News - Watson and Unimed settle lawsuit over testosterone gel.
Friday 1st of September 2006, 12:00 amSeptember 1, 2006 -- Watson Pharmaceuticals, Inc. (Corona, CA), a leading specialty pharmaceutical company, announced that it has reached a settlement with Unimed...